title: Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma.
authors.forename: Anna E C A B
authors.initials: AE
authors.lastname: Willemsen
authors.forename: Carla M L
authors.initials: CM
authors.lastname: van Herpen
authors.forename: Pieter
authors.initials: P
authors.lastname: Wesseling
authors.forename: Peter
authors.initials: P
authors.lastname: Bult
authors.forename: Hanneke W M
authors.initials: HW
authors.lastname: van Laarhoven
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000473:pathology; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care / Q000379:methods; D016879:Salvage Therapy; D057049:Thrombotic Microangiopathies / Q000139:chemically induced* / Q000175:diagnosis; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D003841:Deoxycytidine; D000093542:Gemcitabine